SCHEMBL28488249

SCHEMBL28488249

CNc1cnc(-n2c(=O)[nH]c3ccccc32)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNKS O95271 1/20 0.47
▸ AURKA O14965 4/20 0.45
▸ CDK5 Q00535 1/20 0.43
▸ CDK5R1 Q15078 1/20 0.43
▸ GABRP O00591 4/20 0.41
▸ GABRD O14764 4/20 0.41
▸ GABRA1 P14867 4/20 0.41
▸ GABRB1 P18505 4/20 0.41
▸ GABRG2 P18507 4/20 0.41
▸ GABRB3 P28472 4/20 0.41
▸ GABRA5 P31644 4/20 0.41
▸ GABRA3 P34903 4/20 0.41
▸ GABRA2 P47869 4/20 0.41
▸ GABRB2 P47870 4/20 0.41
▸ GABRA4 P48169 4/20 0.41
▸ GABRE P78334 4/20 0.41
▸ GABRA6 Q16445 4/20 0.41
▸ GABRG1 Q8N1C3 4/20 0.41
▸ GABRG3 Q99928 4/20 0.41
▸ GABRQ Q9UN88 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21464277 0.82 AURKA (0.49) TNKSAURKAGABRPGABRDGABRA1
SCHEMBL30615368 0.82 AURKA (0.49) TNKSAURKAGABRPGABRDGABRA1
SCHEMBL21463397 0.80 LMNA (0.49) TNKSAURKACDK5CDK5R1GABRP
SCHEMBL28489192 0.79 AURKA (0.48) TNKSAURKACDK5CDK5R1GABRP
SCHEMBL21463340 0.78 AURKA (0.46) TNKSAURKAGABRPGABRDGABRA1
SCHEMBL30615478 0.78 AURKA (0.46) TNKSAURKAGABRPGABRDGABRA1
SCHEMBL16456379 0.76 AURKA (0.53) TNKSAURKACDK5CDK5R1GABRP
SCHEMBL5956445 0.74 CDK5 (0.53) TNKSAURKACDK5CDK5R1GABRP
SCHEMBL16455944 0.73 TNKS (0.49) TNKSAURKACDK5CDK5R1GABRP
SCHEMBL21463487 0.73 AURKA (0.45) TNKSAURKAGABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111868037-B Fused cyclic urea derivatives as CRHR2 antagonists 拉夸里亚创药株式会社 2023-10-13 — — CN disclosed
CN-111868037-A Fused cyclic urea derivatives as CRHR2 antagonists 拉夸里亚创药株式会社 2020-10-30 — — CN disclosed
Send feedback